Exit readiness

Distributions as a percentage of NAV have held below 15 per cent for four consecutive years. Buy-side and sell-side valuation gaps are wide. In this market, the sponsors who control the narrative before diligence starts are the ones who clear the exit at the valuation they need.

Introduction

Exits are harder to clear than at any point in the last decade. Bain’s 2026 Global Private Equity Report records distributions as a percentage of NAV below 15 per cent for four consecutive years. Approximately 32,000 portfolio companies remain unsold globally. The average hold period has stretched to 6.7 years, the longest since 2005. In the UK mid-market, buy-side and sell-side valuation gaps are among the widest since the global financial crisis.

These conditions are not a reason to delay going to market. They are a reason to arrive at the exit window better prepared than a buy-side DD team expects. The sponsors who clear exits at the valuations they need in this environment are not the ones with the cleanest businesses. They are the ones with the most defensible evidence for the valuations they are asking buyers to pay.

Customer evidence is the most consequential part of that preparation, and the most consistently underprepared. The buy-side DD team will ask about the customer base. They will ask which customers the revenue is concentrated in, whether the highest-value customers are growing or leaving, whether recent acquisition cohorts are coming in at the same quality as the incumbent base, what the churn trajectory looks like, and whether the customer relationships that underpin the goodwill premium will survive the transaction.

These questions are predictable. The answers, if built on individual customer-level data from the full hold period, are the difference between a contested negotiation and a controlled one.

This article sets out what exit readiness means in the customer evidence context, the specific questions buyers will ask and when they will ask them, how to build the customer evidence layer four to six months before going to market, what vendor due diligence requires from a customer base perspective, and the return on investment of commissioning early rather than scrambling to assemble evidence after the sale process has begun.

Definition Exit readiness in private equity refers to the state of preparedness a sponsor achieves before formally going to market, specifically the completeness and defensibility of the evidence base that supports the valuation being asked. Customer exit readiness means having the customer evidence layer, including concentration data, cohort quality, retention trajectory, and relationship transfer risk scoring, built and documented before the buy-side DD team tables its questions in the deal process.

Why exit readiness is harder in 2026

The exit environment of 2026 is structurally different from the one in which many of the portfolio companies currently preparing to exit were acquired. Three changes compound together to make the customer evidence layer more important than it has been at any previous point in the PE cycle.

The valuation gap

Buy-side and sell-side valuation expectations diverged significantly through 2023 to 2025 and have not fully converged. Buyers are applying more rigorous scrutiny to the revenue assumptions underpinning seller valuations, because the macroeconomic experience of the preceding three years has shown that revenue lines that looked durable before 2022 did not always remain so. Customer base quality, specifically the concentration and retention profile of the revenue base, is one of the primary areas where buyers are applying additional analytical depth to stress-test vendor assumptions.

A sponsor who arrives at the exit process with customer evidence already built, at individual customer level, covering the full hold period, is in a structurally different negotiating position from one who is producing customer analysis for the first time in response to buyer requests. The former controls the narrative. The latter is reactive to the questions.

The diligence timeline

Buy-side diligence timelines have lengthened materially since 2022. Customer-related questions are among the most frequently added items to standard DD checklists. The practical effect is that a sponsor who does not have customer evidence pre-built faces a compressed window in which to produce it, typically under time pressure, with a management team that is simultaneously running the business and managing the sale process. The quality of evidence produced under those conditions is systematically lower than evidence built at leisure, over four to six months, with the full hold period data available.

The distribution imperative

LP patience for extended holds has limits. ILPA’s 2025 to 2026 sentiment survey found that approximately 66 per cent of LPs prefer extended holds for improved MOIC, but that preference is conditional: it applies when the extended hold is visibly improving the asset. The 32,000 unsold portfolio companies globally represent a distribution problem that PE funds need to solve. Sponsors who can demonstrate that their portfolio company is genuinely exit-ready, with a defensible equity story anchored in customer evidence, are better positioned to clear the exit window at the right moment than those who are not.

Section B: The questions buyers will ask

The customer base questions that appear in buy-side diligence are predictable. They have been consistent across UK mid-market and upper-mid-market transactions for the past three years, and they have become more detailed, not less, as buyers have developed more sophisticated commercial due diligence capabilities.

The questions fall into four categories. Understanding the categories is useful because it shows which parts of the customer evidence layer need to be built in advance, and which can be produced reactively without significant risk to the narrative.

Category 1: Concentration and dependency

These questions are asked in every deal where the customer base is a primary value driver. They are the first thing a sophisticated buy-side DD team or CDD adviser will look at, because concentration risk is the most direct source of post-acquisition revenue risk.

What percentage of revenue comes from the top 10 and top 20 customers by value?

What percentage of revenue comes from the top quintile and top decile of the customer base?

Has the concentration ratio improved, held stable, or worsened over the hold period?

Are there any single customers representing more than 10 per cent of revenue? More than 15 per cent?

What is the revenue impact if the top three customers by value do not renew or reduce spend by 20 per cent?

The reason these questions are asked first is that the answers directly affect the buyer’s view of goodwill, the exit multiple, and the risk adjustment to the revenue line in the investment case. In UK mid-market transactions, high concentration is one of the two most consistently cited reasons for multiple discounts, alongside key person dependency. A sponsor who can show that concentration has reduced during the hold, with individual customer-level data, has already addressed the primary valuation risk before it is raised.

Category 2: Cohort quality and acquisition trajectory

These questions probe whether the revenue growth during the hold is durable or whether it is masking a deterioration in acquisition quality. They are asked by buyers who have seen businesses where headline revenue growth during the hold was partially or substantially driven by lower-value customer acquisition.

What does the cohort quality comparison look like across the last four to six acquisition years?

Are recent acquisition cohorts coming in at the same initial spend level as cohorts from three to four years ago?

What is the frequency and breadth profile of the most recent two acquisition cohorts compared to the incumbent base?

Is there a trend in acquisition quality that is visible in the data but not yet in the revenue line?

A sponsor who cannot answer these questions from individual customer-level data, covering the last 24 to 36 months of post-acquisition trading, is vulnerable to a buyer constructing their own answer from the available data and presenting it as a valuation risk. Building the cohort quality evidence in advance removes that vulnerability and replaces it with a pre-prepared answer that frames the finding in the most favourable accurate light.

Category 3: Retention and value-tier migration

These questions establish whether the highest-value customers are stable or quietly deteriorating, and whether the revenue growth during the hold is being driven by the right segment of the customer base.

What is the retention rate in the top quintile of customers by value, and how has it trended over the hold period?

Are customers moving up or down in value tier year on year? Is the net migration positive or negative?

What is the recency profile of the highest-value customer group? Are recent transaction dates improving or worsening?

What does churn look like in the top value tier, and what has driven it where it has occurred?

What proportion of revenue from the highest-value customers at the time of acquisition is still retained?

Value-tier migration is among the most sophisticated questions now appearing in buy-side commercial due diligence. It requires individual customer-level analysis to answer accurately. A sponsor who has run a Customer Base Diagnostic at year 2 and year 4 of the hold has four years of documented migration data. A sponsor who has not has a point-in-time snapshot that cannot demonstrate direction or trajectory.

Category 4: Relationship transfer risk

These questions establish whether the customer relationships underpinning the goodwill premium are attached to the business or to specific individuals in the management team. They are asked in every founder-led deal and in any transaction where the management team is partially or fully exiting.

Which customer relationships are primarily managed through a specific individual in the management team?

Are there customers whose purchasing behaviour is correlated with the tenure of a specific account manager or owner?

What evidence exists that key customer relationships will transfer to new management post-acquisition?

What is the net revenue exposure if the three highest-risk personal relationships do not transfer?

Transaction-level data provides a structurally better answer to these questions than management interviews, which are inherently unreliable because sellers have an incentive to assert that relationships are institutionalised. Customer behaviour analysis shows which customers transact independently of individual contacts and which show patterns consistent with a personal relationship. That picture is observable, not asserted.

Four to six months before going to market

The optimal window for building the customer evidence layer is four to six months before the formal sale process begins, before the bankers are appointed, before the management team is consumed by the sale process, and before time pressure reduces the quality of what can be produced.

In that window, the evidence can be built from a position of control. The diagnostic can be commissioned, completed, and reviewed without the urgency of a live deal process. The findings can be incorporated into the equity story before it is finalised. Weaknesses in the customer evidence can be addressed, either by deepening the evidence or by framing the finding accurately and proactively before a buyer surfaces it as a risk. The data room can be prepared around the customer evidence layer rather than retrofitting it after the fact.

The four-to-six-month timeline

Timing Action Output
Month minus 6 to minus 4 Commission the Customer Base Diagnostic. 12 to 48 months of customer movement data. Concentration, cohort quality, value-tier migration, and relationship transfer risk. The full customer evidence layer.
Month minus 5 to minus 3 Review Diagnostic findings with operating partner and sponsor. Incorporate into equity story development. An equity story in which the customer evidence layer is integrated from the outset, not appended. Customer strengths framed as positives; risks framed accurately and proactively.
Month minus 4 to minus 2 Prepare the data room customer evidence section. Structured data room folder containing: anonymised Diagnostic output, concentration analysis, cohort quality comparison, value-tier migration data, 12-month forward scenarios, and relationship transfer risk summary.
Month minus 3 to minus 1 Brief the sell-side bankers with the customer evidence already built. CIM and information package that reflects the customer base evidence, not just the revenue line. Management presentations anchored in observable data, not assertions.
Deal process Incoming buy-side DD team or CDD adviser asks the four categories of customer question. The data room already contains the answers. Buyer questions are addressed by evidence, not by management responses. The narrative is controlled from the first day of formal diligence.

What the data room needs to contain

The customer evidence section of the data room should address all four question categories in Section B. The standard structure, based on what buyers and their advisers now expect to see in UK mid-market and upper-mid-market deals, is as follows.

Data room tab Content
Customer concentration analysis Revenue distribution across the customer base. Top decile, top quintile, top 20 per cent, and top 10 per cent as a percentage of total revenue. Point-in-time at acquisition, at year 2 or year 3, and at the diagnostic date. Trend direction clearly stated.
Cohort quality comparison Initial spend, frequency, and breadth profile for each of the last four to six annual acquisition cohorts. Comparison against the incumbent base at the equivalent lifecycle stage. Trend direction stated: improving, stable, or deteriorating.
Value-tier migration analysis Year-on-year movement of customers between value tiers across the hold period. Net migration direction (positive or negative). Retention rate in the top value tier, broken out separately from aggregate retention.
12-month forward scenarios High, medium, and low revenue range outcomes based on observed customer migration patterns. Not management projections. Based on observed behaviour extrapolated forward under three scenario assumptions. The difference between the three scenarios is the single most important number in the customer evidence section.
Relationship transfer risk summary Identification of customer relationships with identifiable personal dependency. Estimated revenue exposure. Evidence of relationship transferability where it exists. Honest statement of risk where it does not.
Methodology note A one-page explanation of how the analysis was conducted, by whom, and on what data. This is the provenance statement for the evidence. Buyers and their advisers will check it.

The standard for what buyers expect to see in the customer evidence section of a data room has risen materially over the past three years. Individual customer-level analysis, covering the full hold period and producing documented migration data rather than point-in-time snapshots, is increasingly the expected baseline in upper-mid-market transactions and is becoming standard in the UK mid-market.

Building the customer equity story

The customer evidence layer is not only a risk mitigation tool. Deployed well, it is an offensive element of the equity story: a set of observable facts about the customer base that supports the valuation being asked and pre-empts the objections a buyer would otherwise construct.

A strong customer equity story has three components. Each requires individual customer-level evidence to make credibly.

Component 1: Revenue durability

Revenue durability is the claim that the revenue line will hold under new ownership. It is the most fundamental customer evidence claim in any exit equity story, and the one that buyers are most likely to probe.

The evidence that supports revenue durability is: customer concentration within acceptable bounds (and improving over the hold), high-value customers retained at a rate that is consistent with or better than the thesis at acquisition, breadth of purchasing stable or increasing in the top value tier, and a 12-month forward scenario range that shows the low-case revenue still supporting the investment thesis at a reasonable downside assumption.

What makes this evidence credible is that it comes from individual customer-level analysis of observed transaction data, not from management projections or cohort-level averages. A buyer who can see the actual distribution, migration, and retention data at customer level, covering 12 to 48 months of post-acquisition trading, is looking at a different quality of evidence from one who is reading a management presentation about the strength of the customer relationships.

Component 2: Growth quality

Growth quality is the claim that the revenue growth during the hold is coming from the right kind of customers and will continue under new ownership. This is the component that most directly addresses the buyer’s concern about post-acquisition revenue trajectory.

The evidence that supports growth quality is the cohort quality comparison: documentation that the customers acquired during the hold are coming in at the same or higher value than the customers acquired before it. If cohort quality has improved, the case is strong. If it has held stable, the case is defensible. If it has deteriorated, the evidence needs to be framed honestly and proactively, with an explanation of the specific channel, pricing, or product decisions that drove it and whether they have been corrected.

A sponsor who presents cohort quality evidence before a buyer asks for it, including the context where the finding is less favourable than ideal, builds more credibility than one who presents a selective picture that a buyer’s CDD adviser will subsequently complicate. Buyers in 2026 have access to the same analytical tools that allow them to compute cohort quality from the raw data. The question is whether the seller’s narrative or the buyer’s own analysis frames the finding first.

Component 3: Goodwill defensibility

Goodwill defensibility is the claim that the premium being asked above net asset value is supported by customer relationships and recurring revenue that will transfer with the transaction. This connects directly to the relationship transfer risk question in The Questions Buyers Will Ask section above and to the customer-driven goodwill framework set out in the first article in this series.

The evidence that supports goodwill defensibility is: a clear distinction between the revenue attributable to customer relationships that are embedded in the business versus those that are personal to specific individuals, documentation of the revenue that is at risk from relationship transfer, and evidence that the business has processes, products, or pricing structures that retain customers independently of individual relationships.

This evidence is not available from management interviews, reference calls, or aggregate revenue analysis. It is available from transaction-level data that shows which customers interact through the business independently of individual account relationships, and which show patterns consistent with personal dependency. The Diagnostic produces this picture from observed behaviour, not from management assertion.

The economics of commissioning early

The commissioning decision for exit readiness customer evidence is not budget-constrained in the way entry-stage diligence is. A deal team at entry is managing a competitive process on a compressed timeline with a finite diligence budget. A sponsor preparing for exit is managing their own timeline, on their own schedule, four to six months before the bankers are appointed. The cost of the Customer Base Diagnostic is fixed. The value it creates is a function of the exit EV.

The ROI table

Exit EV Diagnostic cost Illustrative valuation uplift defended (2.5–7.5% of EV)
£50m Scoped to complexity and data volume £1.25m to £3.75m
£100m Scoped to complexity and data volume £2.5m to £7.5m
£200m Scoped to complexity and data volume £5m to £15m
£350m Scoped to complexity and data volume £8.75m to £26.25m
£500m Scoped to complexity and data volume £12.5m to £37.5m

The valuation uplift figure reflects two sources of value: the removal of a concentration discount that a buyer would otherwise apply, and the ability to defend the revenue quality claim against buy-side scrutiny. Both are real mechanisms. Both are documented in UK mid-market transaction data.

The concentration discount data point is consistent: a business with a single customer at more than 15 to 20 per cent of revenue typically takes a 30 to 40 per cent multiple discount relative to a comparable business with a diversified base. At a £200m exit EV, a 5 per cent multiple improvement from demonstrating that concentration has reduced during the hold and is within acceptable bounds is £10m of additional value. The Diagnostic costs Scoped to complexity and data volume. The commissioning decision at the exit stage is not a diligence cost question. It is a return question.

The risk of not commissioning

The risk of arriving at the exit window without pre-built customer evidence is not that the deal fails. It is that the deal clears at a lower valuation than the evidence would have supported, on a timeline that is longer than necessary, with a management team that has spent two months answering DD questions reactively rather than running the business.

In a market where 32,000 portfolio companies are competing for buyer attention and where valuation gaps between buyers and sellers are structurally wide, the quality of the evidence that supports the asking price is a competitive differentiator. The sponsors who consistently clear exits at the valuations they need are the ones who arrive at the exit window with the evidence already built.

Vendor due diligence and the customer base

Vendor due diligence is the formal process by which a seller pre-commissions diligence to present to potential buyers, accelerating the transaction process and reducing the information asymmetry that typically slows it. In the UK mid-market, VDD is standard in formal auction processes and increasingly expected in bilateral transactions above a certain size.

The scope of VDD has expanded since 2022. Customer analysis is now among the most frequently added components to standard VDD mandates. Where it was previously a supplement to the financial and commercial sections, it is becoming a standalone section with its own analytical depth requirements. The expectation, increasingly, is that VDD customer analysis is conducted at individual customer level, not at cohort average.

The Customer Base Diagnostic is the instrument that produces VDD-quality customer analysis. Its output, delivered in approximately 10 days from clean transaction data, covers the full scope of what a VDD customer section now requires: concentration, cohort quality, value-tier migration, retention in the top tier, 12-month forward scenarios, and relationship transfer risk. The Diagnostic is not a bespoke piece of work for each transaction. It is a replicable instrument that produces a consistent, comparable output across any portfolio company where transaction-level data is available.

The vendor due diligence use case

A sponsor commissioning VDD four to six months before going to market can include the Customer Base Diagnostic as the customer analytics layer within the broader VDD mandate, or as a standalone customer evidence deliverable that sits alongside the VDD report in the data room. Either approach produces the same output: a customer evidence layer that is available to buyers from day one of the formal process, reducing the time pressure on the DD timeline and the information vacuum that typically drives the most aggressive buy-side assumptions.

The practical effect is that the buy-side team’s CDD adviser, when they begin their work, starts from the position of reviewing and challenging the seller’s customer evidence rather than constructing their own picture from scratch. This is a structurally better starting point for the seller: it means the buyer’s DD conclusions are constrained by the quality of the evidence already in the room, rather than being constructed in an information vacuum that the buyer fills with their most conservative assumptions.

Closing: Control the narrative before diligence starts

Exit readiness is not a checklist. It is a posture. It is the decision to arrive at the exit window with the evidence already built, rather than assembling it reactively in response to buyer questions. In the customer base context, it is the decision to commission the analysis four to six months before the bankers are appointed, to incorporate the findings into the equity story from the outset, and to present the data room as a controlled narrative rather than a set of reactive responses.

The questions buyers will ask about the customer base in 2026 are predictable. The answers, if built on individual customer-level data covering the full hold period, are the difference between a contested negotiation and a controlled one. A sponsor who can answer all four categories of customer question, with documented evidence at individual customer level, before a buy-side DD team tables a single request, has a structural advantage in the exit process that is not available to sponsors who are producing that evidence for the first time in response to the request.

The instrument that builds that evidence, the Customer Base Diagnostic, takes approximately 10 days from clean transaction data. At exit stage, at the valuations at which UK mid-market and upper-mid-market transactions clear, the commissioning decision is straightforward. The question is not whether the evidence is worth building. It is how far in advance it needs to be commissioned to arrive in the data room at the right moment.

Commission the Customer Base Diagnosticapproximately 10 days from clean data. Four to six months before going to market. The full customer evidence layer: concentration, cohort quality, value-tier migration, 12-month forward scenarios, relationship transfer risk. Scoped to complexity and data volume. No PII required. keystoneiq.co/customer-base-diagnostic

Download: The Exit Readiness GuideBuild the customer evidence layer before the buyer’s DD team asks for it. The ten-page guide to exit preparation from a customer evidence perspective. keystoneiq.co/downloads/exit-readiness-guide

Read alsoClosing the MOIC Gap: how the hold-period work leads to the exit result. keystoneiq.co/insights/closing-the-moic-gap

Read alsoCustomer-Driven Goodwill: how customer evidence supports the goodwill premium at exit. keystoneiq.co/insights/customer-driven-goodwill

FAQs

Exit readiness in private equity is the state of preparedness a sponsor achieves before formally going to market: specifically the completeness and defensibility of the evidence base that supports the valuation being asked. Customer exit readiness means having the customer evidence layer, including concentration data, cohort quality, retention trajectory, and relationship transfer risk scoring, built and documented before the buy-side due diligence team tables its questions in the deal process.

Preparing for a PE exit from a customer evidence perspective requires four steps: commission a Customer Base Diagnostic four to six months before going to market; incorporate the findings into the equity story before the bankers are appointed; prepare the data room customer evidence section covering concentration, cohort quality, value-tier migration, forward scenarios, and relationship transfer risk; and brief the sell-side bankers with the evidence already built, so the CIM reflects observed customer behaviour rather than management assertion.

Buyers ask four categories of customer base question at exit: concentration and dependency (what percentage of revenue rests on the top customers and has it improved); cohort quality and acquisition trajectory (are recent customers coming in at the same value as the incumbent base); retention and value-tier migration (are the highest-value customers stable or leaving); and relationship transfer risk (which customer relationships are personal to the exiting management team rather than embedded in the business).

The data room customer evidence section should contain: a customer concentration analysis showing the revenue distribution at acquisition, mid-hold, and exit; a cohort quality comparison across the last four to six acquisition years; a value-tier migration analysis showing year-on-year movement between customer segments; 12-month forward revenue scenarios based on observed migration patterns; a relationship transfer risk summary; and a methodology note explaining how the analysis was conducted and on what data.

Vendor due diligence is the formal process by which a seller pre-commissions diligence reports to present to potential buyers, reducing information asymmetry and accelerating the transaction timeline. Customer VDD analysis is now a standard component of UK mid-market and upper-mid-market VDD mandates. It is increasingly expected at individual customer level, covering concentration, cohort quality, value-tier migration, and forward revenue scenarios, rather than at cohort average.

A credible customer equity story for a PE exit has three components: revenue durability, demonstrated by customer concentration within acceptable bounds and high-value customer retention across the hold; growth quality, demonstrated by cohort quality evidence that recent acquisition is coming in at the same or higher value than the incumbent base; and goodwill defensibility, demonstrated by transaction-level evidence distinguishing enterprise customer relationships from personal ones that are attached to the exiting management team.

Talk to us about your customer base

Days not weeks. Fixed scope. No PII required.

Get in Touch